Giapreza

Angiotensin II · La Jolla Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Giapreza, covering 2017-12-21 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Angiotensin II for Distributive Shock [Phase 4]